Condition
Octa
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Early P 1 (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06797752RecruitingPrimary
Effect of the Stellate Ganglion Block on the Retinal Microcirculation
NCT06797765RecruitingPrimary
Optical Coherence Tomography Angiography in Neurological Disease
NCT04493073Early Phase 1UnknownPrimary
Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy
Showing all 3 trials